Literature DB >> 10760313

High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer.

M E Lippman.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10760313     DOI： 10.1056/NEJM200004133421508

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer.

Authors:  H Gilbert Welch; Juliana Mogielnicki
Journal:  BMJ       Date:  2002-05-04

2.  Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology.

Authors:  Alois Gratwohl; Alvin Schwendener; Helen Baldomero; Michael Gratwohl; Jane Apperley; Dietger Niederwieser; Karl Frauendorfer
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

Review 3.  Maximum tolerated dose: clinical endpoint for a bygone era?

Authors:  Chris H Takimoto
Journal:  Target Oncol       Date:  2009-04-18       Impact factor: 4.493

4.  Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.

Authors:  Yanyan Li; Tao Zhang; Hasan Korkaya; Suling Liu; Hsiu-Fang Lee; Bryan Newman; Yanke Yu; Shawn G Clouthier; Steven J Schwartz; Max S Wicha; Duxin Sun
Journal:  Clin Cancer Res       Date:  2010-04-13       Impact factor: 12.531

Review 5.  Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.

Authors:  Yanyan Li; Max S Wicha; Steven J Schwartz; Duxin Sun
Journal:  J Nutr Biochem       Date:  2011-02-04       Impact factor: 6.048

6.  Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

Review 7.  Stem cells and cancer: an overview.

Authors:  Kevin M Sales; Marc C Winslet; Alexander M Seifalian
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 8.  Integrating evolutionary dynamics into cancer therapy.

Authors:  Robert A Gatenby; Joel S Brown
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675

9.  Oncology consent forms: failure to disclose off-site treatment availability.

Authors:  David B Resnik; Shyamal Peddada; Jason Altilio; Nancy Wang; Jerry Menikoff
Journal:  IRB       Date:  2008 Nov-Dec

Review 10.  Whither high-dose chemotherapy in breast cancer?

Authors:  A Mayer; H Earl
Journal:  Breast Cancer Res       Date:  2000-11-08       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.